Metropolis Healthcare Ltd's Q3FY25 Quarterly Results

Result Summary

• Metropolis Healthcare Ltd reported a 7.8% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Dec (Q3FY25). On a year-on-year (YoY) basis, it witnessed a growth of 10.9%.
• Its expenses for the quarter were down by 2.9% QoQ and up 10.3% YoY.
• The net profit decreased 32.6% QoQ and increased 15.3% YoY.
• The earnings per share (EPS) of Metropolis Healthcare Ltd stood at 6.1 during Q3FY25.

Financial Statments for Q3FY25

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Metropolis Healthcare Ltd is a leading diagnostic company in India, primarily engaged in providing pathology and diagnostic services. The company operates in the healthcare sector, which is a crucial industry supporting public health through medical testing and diagnostics. Metropolis Healthcare has a network of diagnostic laboratories and collection centers across various locations, which facilitates a wide range of pathology tests and health check-ups. The company is known for its focus on quality and reliability of test results, catering to the needs of hospitals, laboratories, and individual patients. As of the most recent updates, there are no specific major developments available for Metropolis Healthcare Ltd beyond its ongoing operations and market presence.

Revenue

In Q3FY25, Metropolis Healthcare Ltd reported a total income of ₹325.32 crores. This represents a decrease of 7.8% on a quarter-over-quarter (QoQ) basis from ₹352.92 crores in Q2FY25. However, when compared to the same quarter of the previous financial year, Q3FY24, there is a year-over-year (YoY) increase of 10.9% from ₹293.42 crores. The YoY growth indicates an increase in revenue generation over the past year, despite the recent QoQ decline. The revenue performance is a critical indicator of the company's ability to maintain its market share and expand in the diagnostic services sector.

Profitability

Metropolis Healthcare Ltd's profitability metrics for Q3FY25 show a profit before tax (PBT) of ₹42.34 crores, which is a 31.0% decline QoQ from ₹61.40 crores in Q2FY25. Compared to Q3FY24, there is a YoY increase of 14.9% from ₹36.85 crores. The tax expense for Q3FY25 was ₹10.86 crores, down by 26.1% QoQ from ₹14.70 crores in Q2FY25, and up by 13.5% YoY from ₹9.57 crores. Profit after tax (PAT) for Q3FY25 amounted to ₹31.47 crores, marking a 32.6% decrease from the previous quarter's ₹46.70 crores. However, it represents a 15.3% increase from Q3FY24, where the PAT was ₹27.29 crores. The earnings per share (EPS) for the quarter was ₹6.10, down 32.2% QoQ from ₹9.00, but up 15.1% YoY from ₹5.30. These figures reflect the company's profit margins and tax efficiencies over the specified periods.

Operating Metrics

The operating metrics for Metropolis Healthcare Ltd in Q3FY25 include total expenses amounting to ₹282.99 crores, which shows a decrease of 2.9% QoQ from ₹291.52 crores in Q2FY25. Comparing YoY, there is an increase of 10.3% from ₹256.57 crores in Q3FY24. These operating expenses highlight the cost structure and spending efficiency of the company during the period. The decrease in expenses QoQ, despite the reduction in total income, demonstrates the company's operational adjustments. Additionally, the YoY increase in expenses is aligned with the YoY increase in total income, suggesting consistent operational scaling. The analysis of these metrics provides insights into the company’s cost management and efficiency in resource allocation.